Physician profile
Michael T Clarke
NPI 1871598805
$112,312.17
in general payments reported to CMS, 2019-2025
10 companies · $3,970 in 2025
The $3,970 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44K · 2020: $40K · 2021: $10K · 2022: $8,140 · 2023: $2,654 · 2024: $3,637 · 2025: $3,970.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,056 · Travel and Lodging: $4,206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,055.82 |
| Travel and Lodging | $4,205.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lima USA, INC. | $63,272.76 | 2019-2022 | |
| Limacorporate S.P.A. | $27,746.55 | 2019-2022 | |
| Stryker Corporation | $14,452.65 | 2019-2025 | Accolade, Triathlon, Exeter |
| Smith+Nephew, INC. | $3,702.40 | 2019-2025 | Healicoil, Bone Anchors With Arthroscopic Delivery System, Q-Fix |
| Encore Medical, Lp | $2,664.60 | 2024-2025 | Djo Surgical |
| Depuy Synthes Sales INC. | $214.29 | 2019-2023 | |
| Uoc USA INC | $115.13 | 2025 | Uts, Conformity, U-Mii, U2 Revision Stem, Psa, Ustar, U2 Knee |
| Zimmer Biomet Holdings, INC. | $98.82 | 2021 | |
| Ethicon US, LLC | $34.38 | 2024 | Dermabond Prineo, Stratafix |
| Heraeus Medical, LLC. | $10.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Clarke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.